UnitedHealth Group (NYSE:UNH – Get Free Report) had its price objective reduced by investment analysts at Truist Financial from $625.00 to $610.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the healthcare conglomerate’s stock. Truist Financial’s price target points to a potential upside of 18.91% from the company’s previous close.
A number of other brokerages have also recently issued reports on UNH. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Barclays upped their price target on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, KeyCorp started coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $627.58.
View Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Stock Up 1.7 %
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm posted $6.56 earnings per share. Equities research analysts expect that UnitedHealth Group will post 27.61 earnings per share for the current fiscal year.
Institutional Trading of UnitedHealth Group
A number of institutional investors have recently made changes to their positions in UNH. Delta Financial Group Inc. lifted its position in UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares in the last quarter. Fiduciary Group LLC boosted its position in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after acquiring an additional 18 shares during the last quarter. First PREMIER Bank raised its stake in UnitedHealth Group by 7.0% during the third quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after purchasing an additional 18 shares during the period. Genesee Capital Advisors LLC grew its stake in shares of UnitedHealth Group by 1.9% in the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after buying an additional 18 shares during the period. Finally, Jmac Enterprises LLC grew its position in UnitedHealth Group by 2.2% in the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after acquiring an additional 18 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- What is Forex and How Does it Work?
- Semiconductor Sector Primed for a Major Breakout
- What is the Australian Securities Exchange (ASX)
- From Laggards to Leaders: 3 Stocks Ready to Rebound in 2025
- What is the Euro STOXX 50 Index?
- 3 Momentum Picks From 2024 Poised for More Gains in 2025
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.